Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 11
1 November 1998
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Editorial

Therapeutic innovation: the up-front window.
E Frei, 3rd
View articletitled, Therapeutic innovation: the up-front window.
Open the PDF for in another window

Advances in Brief

Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
W M Lin; E Forgacs; D P Warshal; I T Yeh; J S Martin; R Ashfaq; C Y Muller
View articletitled, Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Open the PDF for in another window
Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma.
P Cattani; S Hohaus; A Bellacosa; M Genuardi; S Cavallo; V Rovella; G Almadori; G Cadoni; J Galli; M Maurizi; G Fadda; G Neri
View articletitled, Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma.
Open the PDF for in another window

Research Articles

Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography.
U Lassen; P Andersen; G Daugaard; S Holm; M Jensen; C Svarer; H S Poulsen; O B Paulson
View articletitled, Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography.
Open the PDF for in another window
Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.
P S Multani; S O'Day; L M Nadler; M L Grossbard
View articletitled, Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.
Open the PDF for in another window
Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
T Utsunomiya; S Yonezawa; H Sakamoto; H Kitamura; S Hokita; T Aiko; S Tanaka; T Irimura; Y S Kim; E Sato
View articletitled, Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Open the PDF for in another window
Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
M Sarbia; M Stahl; A zur Hausen; K Zimmermann; L Wang; U Fink; H Heep; P Dutkowski; R Willers; W Müller; S Seeber; H E Gabbert
View articletitled, Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities.
Open the PDF for in another window
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
G Gasparini; P C Brooks; E Biganzoli; P B Vermeulen; E Bonoldi; L Y Dirix; G Ranieri; R Miceli; D A Cheresh
View articletitled, Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
Open the PDF for in another window
Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
V Schirrmacher; S Müerköster; V Umansky
View articletitled, Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
Open the PDF for in another window
Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.
K Reiss; C D'Ambrosio; X Tu; C Tu; R Baserga
View articletitled, Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.
Open the PDF for in another window
Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells.
S Ghosh; Y Zheng; X Jun; R K Narla; S Mahajan; C Navara; C Mao; E A Sudbeck; F M Uckun
View articletitled, Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells.
Open the PDF for in another window
Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
S Zhang; H S Zhang; C Cordon-Cardo; G Ragupathi; P O Livingston
View articletitled, Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens.
Open the PDF for in another window
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.
S D Gore; E K Rowinsky; C B Miller; C Griffin; T L Chen; M Borowitz; R C Donehower; K L Burks; D K Armstrong; P J Burke; M R Grever; S H Kaufmann
View articletitled, A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia.
Open the PDF for in another window
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
F M Foss; A Raubitscheck; J L Mulshine; T A Fleisher; J C Reynolds; C H Paik; R D Neumann; C Boland; P Perentesis; M R Brown; J M Frincke; C P Lollo; S M Larson; J A Carrasquillo
View articletitled, Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
Open the PDF for in another window
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
A Korfel; M E Scheulen; H J Schmoll; O Gründel; A Harstrick; M Knoche; L M Fels; M Skorzec; F Bach; J Baumgart; G Sass; S Seeber; E Thiel; W E Berdel
View articletitled, Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Open the PDF for in another window
Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
D Choi; M Perrin; S Hoffmann; A E Chang; V Ratanatharathorn; J Uberti; K T McDonagh; J J Mulé
View articletitled, Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells.
Open the PDF for in another window
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Z Rahman; J Kavanagh; R Champlin; R Giles; E Hanania; S Fu; Z Zu; R Mehra; F Holmes; A Kudelka; D Claxton; C Verschraegen; J Gajewski; M Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; E Mechetner; T Holzmayer; A Dayne; J Hamer; C Bachier; J Ostrove; A Deisseroth
View articletitled, Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Open the PDF for in another window
Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
E Felip; B Massuti; C Camps; D Benito; D Isla; J L González-Larriba; M P López-Cabrerizo; O Salamanca; J Puerto-Pica; A Moyano; J Baselga; R Rosell
View articletitled, Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.
Open the PDF for in another window
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
C R Divgi; N H Bander; A M Scott; J A O'Donoghue; G Sgouros; S Welt; R D Finn; F Morrissey; P Capitelli; J M Williams; D Deland; A Nakhre; E Oosterwijk; S Gulec; M C Graham; S M Larson; L J Old
View articletitled, Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma.
Open the PDF for in another window
Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
S W Taber; V H Fingar; C T Coots; T J Wieman
View articletitled, Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
Open the PDF for in another window
Irinotecan (CPT-11) metabolism and disposition in cancer patients.
A Sparreboom; M J de Jonge; P de Bruijn; E Brouwer; K Nooter; W J Loos; R J van Alphen; R H Mathijssen; G Stoter; J Verweij
View articletitled, Irinotecan (CPT-11) metabolism and disposition in cancer patients.
Open the PDF for in another window
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
J Cassidy; L Dirix; D Bissett; B Reigner; T Griffin; D Allman; B Osterwalder; A T Van Oosterom
View articletitled, A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
Open the PDF for in another window
A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
M Hidalgo; G Rodriguez; J G Kuhn; T Brown; G Weiss; J P MacGovren; D D Von Hoff; E K Rowinsky
View articletitled, A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
Open the PDF for in another window
Elevated serum levels of Trichosanthes japonica agglutinin-I binding alkaline phosphatase in relation to high-risk groups for hepatocellular carcinomas.
K Fukushima; T Hada; K Higashino; K Yamashita
View articletitled, Elevated serum levels of Trichosanthes japonica agglutinin-I binding alkaline phosphatase in relation to high-risk groups for hepatocellular carcinomas.
Open the PDF for in another window
Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
H B Salvesen; O E Iversen; L A Akslen
View articletitled, Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Open the PDF for in another window
Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.
A D Lazar; M R Winter; C P Nogueira; P S Larson; E M Finnemore; R W Dolan; N Fuleihan; A Chakravarti; A Zietman; C L Rosenberg
View articletitled, Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease.
Open the PDF for in another window
High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy.
R A Cooper; D P Wilks; J P Logue; S E Davidson; R D Hunter; S A Roberts; C M West
View articletitled, High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy.
Open the PDF for in another window
Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
I Y Cheung; D Barber; N K Cheung
View articletitled, Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.
Open the PDF for in another window
Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
H Ito; S Kyo; T Kanaya; M Takakura; K Koshida; M Namiki; M Inoue
View articletitled, Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer.
Open the PDF for in another window
Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Q Ren; V Kao; J L Grem
View articletitled, Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
Open the PDF for in another window
DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
A F Carpentier; M R Rosenfeld; J Y Delattre; R G Whalen; J B Posner; J Dalmau
View articletitled, DNA vaccination with HuD inhibits growth of a neuroblastoma in mice.
Open the PDF for in another window
A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.
Y Akamatsu; J C Murphy; K F Nolan; P Thomas; R J Kreitman; S O Leung; R P Junghans
View articletitled, A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells.
Open the PDF for in another window
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.
G Pratesi; M De Cesare; C Caserini; P Perego; L Dal Bo; D Polizzi; R Supino; M Bigioni; S Manzini; E Iafrate; C Salvatore; A Casazza; F Arcamone; F Zunino
View articletitled, Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts.
Open the PDF for in another window
Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.
J A Houghton; R Ebanks; F G Harwood; D M Tillman
View articletitled, Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells.
Open the PDF for in another window
Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
P A Bunn, Jr; B A Helfrich; D G Brenner; D C Chan; D J Dykes; A J Cohen; Y E Miller
View articletitled, Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo.
Open the PDF for in another window
Antileukemia activity of a natural killer cell line against human leukemias.
Y Yan; P Steinherz; H G Klingemann; D Dennig; B H Childs; J McGuirk; R J O'Reilly
View articletitled, Antileukemia activity of a natural killer cell line against human leukemias.
Open the PDF for in another window
Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
S R Evans; A M Schwartz; E I Shchepotin; M Uskokovic; I B Shchepotin
View articletitled, Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft.
Open the PDF for in another window
Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
J A Bennett; S Zhu; A Pagano-Mirarchi; T A Kellom; H I Jacobson
View articletitled, Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Open the PDF for in another window
Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells.
D S Schrump; W Matthews; G A Chen; A Mixon; N K Altorki
View articletitled, Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells.
Open the PDF for in another window
Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.
S L Berg; D J Murry; C L McCully; K Godwin; F M Balis
View articletitled, Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate.
Open the PDF for in another window
Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro.
E Marshman; D R Newell; A H Calvert; A M Dickinson; H R Patel; F C Campbell; N J Curtin
View articletitled, Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro.
Open the PDF for in another window
Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.
R M Conry; S A White; P N Fultz; M B Khazaeli; T V Strong; K O Allen; D L Barlow; S E Moore; P N Coan; I Davis; D T Curiel; A F LoBuglio
View articletitled, Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen.
Open the PDF for in another window
Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.
S D Drenning; A J Marcovitch; D E Johnson; M F Melhem; D J Tweardy; J R Grandis
View articletitled, Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium.
Open the PDF for in another window

Advertisement

Breaking
$500,000 Purse Announced for TBXT Drugs
B7-H4 Inhibitor Effective for Some Triple-Negative Breast Cancers
CAR-Related T-Cell Malignancies Rare, Another Study Finds
View more recent articles
Latest News
Greater Certainty of Survival Valued Over Speedier Drug Access
Keto Diet Key to Fueling CARs?
ADC for Lymphoma Elicits Near-Perfect Response Rate
View more recent articles
Research Watch
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept